17 Mar, 13:59 - Indian

Nifty Bank 54619.6 (0.38)

Nifty Pharma 22642.6 (0.42)

Nifty Next 50 64802.3 (0.53)

Nifty 50 23547.5 (0.59)

Nifty Smallcap 100 15898.65 (0.56)

Nifty IT 28822.9 (-0.76)

SENSEX 75966.21 (0.61)

Nifty Midcap 100 55010.7 (0.72)

17 Mar, 13:59 - Global

NIKKEI 225 53700.39 (-0.09)

HANG SENG 25868.55 (0.13)

S&P 6733.75 (0.25)


Corporate News

You are Here : Home > News > Corporate News >

(17 Mar 2026, 11:36)

Camlin Fine Sciences postpones acquisition of balance stake in Vinpai


Camlin Fine Sciences (CFSL) has completed the acquisition of on 27 November 2025, by way of contribution in kind, of a majority stake in the share capital of Vinpai (ISIN: FR001400AXT1; mnémonique : ALVIN) representing 78,68% of share capital et 84.89% of voting rights of Vinpai, at a price of Euro 3.60 per Vinpai share (block acquisition) from significant shareholders (sellers).

Additionally, CFSL was allotted 1,100,000 new ordinary shares of Vinpai on conversion of convertible bonds on 20 October 2025.

Following the block acquisition and conversion of convertible bonds, CFSL now holds 83.82% stake in Vinpai's share capital and 80.86% of its voting rights.

On 23 December 2025, CFSL had announced that it would file, by end of February 2026  a simplified cash tender offer (offre publique d'achat simplifiée) (OPAS) with the French Stock Markets Authority (AMF) for the remaining shares of Vinpai, at the same price as that of the block acquisition, i.e. Euro 3.60 per Vinpai share.

However, due to administrative constraints specific to CFSL related to Indian foreign exchange regulations and due to the proximity of the announced publication date of Vinpai's 2025 annual financial statements on 16 April  2026, CFSL announces that it will have to postpone the filing of its OPAS with the purchase price per Vinpai share under the OPAS remaining at Euro 3.60.

Such filing would take place no later than early May 2026 so that the aforementioned Vinpai financial statements may be incorporated into the documentation relating to the OPAS, and into the independent expert's report.

Furthermore, CFSL is looking at the feasible options for restructuring of its group in Europe, to promote synergies among its European subsidiaries and strengthen its presence in Europe. In view of the same, CFSL wishes to keep Vinpai listed.

Consequently, CFSL announces that it no longer intends to implement a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.

Maintaining this listing will allow Vinpai to retain market visibility and have access to the financial markets, ensuring its debt restructuring and supporting the financing of the project's development in Europe, that CFSL group may pursue in the future.

 


More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +